2006—2020年苏州市胰腺癌死亡及减寿分析

doi:10.19485/j.cnki.issn2096-5087.2022.02.016

预防医学

2022, Vol. 34

Issue (2): 185-189 DOI: 10.19485/j.cnki.issn2096-5087.2022.02.016

疾病控制

本期目录 | 过刊浏览 | 高级检索

2006—2020年苏州市胰腺癌死亡及减寿分析

王临池, 黄春妍, 华钰洁, 吴学飞, 陆艳

苏州市疾病预防控制中心慢性病防制科,江苏苏州 215004

Analysis of mortality and life loss due to pancreatic cancer in SuzhouCity from 2006 to 2020

WANG Linchi, HUANG Chunyan, HUA Yujie, WU Xuefei, LU Yan

Department of Non-communicable Disease Control and Prevention, Suzhou Center for Disease Control and Prevention, Suzhou, Jiangsu 215004, China

摘要
参考文献
相关文章
Metrics

全文: PDF(808 KB)
输出: BibTeX | EndNote (RIS)

摘要目的了解2006—2020年苏州市居民胰腺癌死亡趋势和减寿情况,为胰腺癌防治提供依据。方法通过江苏省人口死亡原因登记系统收集2006—2020年苏州市胰腺癌死亡病例资料,计算粗死亡率、标化死亡率、潜在减寿年数（YPLL）、减寿率（YPLLR）、平均减寿年数（AYLL）和年度变化百分比（APC）,分析胰腺癌死亡率的变化趋势及寿命损失情况。结果 2006—2020年苏州市胰腺癌粗死亡率为13.57/10万,呈上升趋势（P<0.05）,APC值为2.95%;标化死亡率为6.39/10万。男性粗死亡率为15.14/10万,女性粗死亡率为12.06/10万,均呈上升趋势（P<0.05）,APC值分别为3.18%和2.73%。30~<45岁和45~<60岁人群胰腺癌粗死亡率呈下降趋势（P<0.05）,APC值分别为-4.93%和-1.63%;≥60岁人群呈上升趋势（P<0.05）,APC值为0.53%。2006—2020年苏州市居民胰腺癌YPLL为55 340人年,YPLLR为0.06%;AYLL为9.81年/人,呈下降趋势（P<0.05）,APC值为-2.35%。结论 2006—2020年苏州市胰腺癌粗死亡率呈上升趋势,AYLL呈下降趋势。应针对男性和老年人群开展胰腺癌防治健康教育和筛查工作。

	服务

	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	王临池
	黄春妍
	华钰洁
	吴学飞
	陆艳

关键词 ：胰腺癌, 死亡率, 潜在减寿年数

Abstract：Objective To investigate the mortality trends and life loss due to pancreatic cancer death among residents in Suzhou City from 2006 to 2020, so as to provide insights into the management of pancreatic cancer. Methods The data pertaining to the death of pancreatic cancer in Suzhou City from 2006 to 2020 were collected from the Jiangsu provincial mortality surveillance system. The crude mortality, standardized mortality, years of potential life lost ( YPL L), rate of YPLL ( YPLLR ), average years of life lost ( AYLL ) and annual percent change (APC) were calculated to analyze the changing trend in mortality and life loss due to pancreatic cancer. Results The crude mortality of pancreatic cancer was 13.57/10⁵ in Suzhou City from 2006 to 2020, appearing a tendency towards a rise ( P<0.05) with APC of 2.95%. The standardized mortality of pancreatic cancer was 6.39/10⁵. The crude mortality of pancreatic cancer was 15.14/10⁵ in men and 12.06/10⁵ in women, which both showed a tendency towards a rise ( P<0.05 ) with APC of 3.18% and 2.73%. The crude mortality of pancreatic cancer appeared a tendency towards a decline in residents at ages of 30 to 45 years and 45 to 60 years ( P<0.05 ), with APC of -4.93% and -1.63%, and appeared a tendency towards a rise in residents at ages of 60 years and greater ( P<0.05 ), with APC of 0.53%. The YPLL and YPLLR of pancreatic cancer were 55 340 person-years and 0.06% in Suzhou City from 2006 to 2020, while the AYLL of pancreatic cancer was 9.81 years per person, which appeared a tendency towards a decline ( P<0.05 ), with APC of -2.35%. Conclusions The crude mortality of pancreatic cancer appeared a tendency towards a rise in Suzhou City from 2006 to 2020, and the AYLL showed a tendency towards a decline. Health education and screening of pancreatic cancer should be reinforced among men and the elderly.

Key words： pancreatic cancer mortality rate years of life potential lost

收稿日期: 2021-10-18 修回日期: 2021-11-10 出版日期: 2022-02-10

中图分类号:

R195

基金资助:江苏省预防医学科研课题(Y2018032); 苏州市医学重点学科(Szxk201816); 苏州市科技局民生科技项目(SYS2018098,SS201807); 苏州市重大疾病、传染病预防和控制关键技术研究(GWZX201901)

通信作者: 陆艳,E-mail: 673261024@qq.com .

作者简介: 王临池,硕士,副主任医师,主要从事慢性病流行病学研究

引用本文:

王临池, 黄春妍, 华钰洁, 吴学飞, 陆艳. 2006—2020年苏州市胰腺癌死亡及减寿分析[J]. 预防医学, 2022, 34(2): 185-189.
WANG Linchi, HUANG Chunyan, HUA Yujie, WU Xuefei, LU Yan. Analysis of mortality and life loss due to pancreatic cancer in SuzhouCity from 2006 to 2020. Preventive Medicine, 2022, 34(2): 185-189.

链接本文:

http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2022.02.016 或 http://www.zjyfyxzz.com/CN/Y2022/V34/I2/185

[1] SUNG H,FERLAY J,SIEGEL R L.Global cancer statistics2020:GLOBOCAN stimates of incidence and mortality worldwide for 36 cancers in 185 countries[J/OL].CA Cancer J Clin,2021[2021-11-10].https: //acsjournals.onlinelibrary.wiley.com/doi/pdf direct/10.3322/caac.21660.
[2] SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics,2020[J].CA Cancer J Clin,2020,70(1):7-30.
[3] 郝捷,魏文强.2019中国肿瘤登记年报[D].北京:人民卫生出版社,2021:156-160.
HAO J,WEI W Q.China cancer registry annual repert,2019[D].Beijing:People's Medical Publishing House,2021:156-160.
[4] 蔡洁,陈宏达,卢明,等.2005—2015年中国胰腺癌发病与死亡趋势分析[J].中华流行病学杂志,2021,42(5):794-800.
CAI J,CHEN H D,LU M,et al.Trend analysis on morbidity and mortality of pancreatic cancer in China,2005-2015[J].Chin J Epidemiol,2021,42(5):794-800.
[5] 王临池,陆艳,胡一河.2004—2013年苏州市居民恶性肿瘤死亡及减寿分析[J].现代预防医学,2015,42(7):1302-1305.
WANG L C,LU Y,HU Y H,et al.Death causes and life lost of malignant tumor among residents in Suzhou City,2004- 2013[J].Mod Prev Med,2015,42(7):1302-1305.
[6] 俞浩,武鸣,林萍,等.江苏省新增死因监测点2011—2012年死亡漏报调查[J].江苏预防医学,2014,25(4):29-32.
YU H,WU M,LIN P,et al.Investigation of under-reporting of death in newly added disease surveillance points in Jiangsu from 2011 to 2012[J].Jiangsu J Prev Med,2014,25(4):29-32.
[7] 周晓燕,龚巍巍,潘劲,等.浙江省公共卫生监测区居民死亡漏报情况分析[J].预防医学,2021,33(10):994-997.
ZHOU X Y,GONG W W,PAN J,et al.Under reporting deaths in public health surveillance areas of Zhejiang Province[J].Prev Med,2021,33(10):994-997.
[8] 韩仁强,武鸣,缪伟刚,等.2016年江苏省恶性肿瘤流行情况分析[J].实用肿瘤学杂志,2020,34(4):291-297.
HAN R Q,WU M,MIAO W G,et al.Malignant tumor epidemiology in Jiangsu province,2016[J].Pract Oncol J,2020,34(4):291-297.
[9] 王亮亮,丁高恒,陈莉莉,等.2009—2015年甘肃省肿瘤登记地区胰腺癌流行特征及变化趋势分析[J].实用肿瘤学杂志,2021,35(3):200-206.
WANG L L,DING G H,CHEN L L,et al.Trends of incidence and mortality of pancreatic cancer in Gansu cancer registration areas,2009-2015[J].Pract Oncol J,2021,35(3):200-206.
[10] 孙惠昕,张茂祥,贾海晗,等.2013—2017年黑龙江省居民胰腺癌发病和死亡趋势[J].预防医学,2021,33(6):599-601.
SUN H X,ZHANG M X,JIA H H,et al.Incidence and mortality of pancreatic cancer in Heilongjiang Province from 2013 to 2017[J].Prev Med,2021,33(6):599-601.
[11] 梁智恒,李柱明,魏矿荣.1970—2015年广东省中山市胰腺癌发病与死亡分析[J].中国肿瘤,2020,29(10):751-757.
LIANG Z H,LI Z M,WEI K R.Incidence and mortality of pancreatic cancer in Zhongshan City of Guangdong Province,1970-2015[J].China Cancer,2020,29(10):751-757.
[12] 纪威,张良,应焱燕,等.2010—2018年宁波市胰腺癌发病和死亡趋势分析[J].预防医学,2020,3(8):805-808.
JI W,ZHANG L,YING Y Y,et al.Trend of pancreatic cancer incidence and mortality in Ningbo from 2010 to 2018[J].Prev Med,2020,3(8):805-808.
[13] LUCAS A L,MALVEZZI M,CARIOLI G,et al.Global trends in pancreatic cancer mortality from 1980 through 2013 and predictions for 2017[J].Clin Gastroenterol Hepatol,2016,14(10):1452-1462.
[14] KLEINA P.Pancreatic cancer epidemiology:understanding the role of lifestyle and inherited risk factors[J].Nat Rev Gastroenterol Hepatol,2021,18(7):493-502.
[15] 刘成成,石春雷,石菊芳,等.2015—2017年中国城市居民肿瘤预防意识健康素养及相关因素分析[J].中华预防医学杂志,2020,54(1):47-53.
LIU C C,SHI C L,SHI J F,et al.Study on the health literacy and related factors of the cancer prevention consciousness among urban residents in China from 2015 to 2017.[J].Chin J Prev Med,2020,54(1):47-53.

[1]	张铁威, 张艳, 刘冰, 秦康, 李标, 徐珏. 2013—2021年杭州市糖尿病死亡及疾病负担分析[J]. 预防医学, 2023, 35(9): 752-756.
[2]	王永, 包凯芳, 王思嘉, 陈洁平, 崔军, 应焱燕, 朱银潮, 李思萱, 徐典. 2011—2022年宁波市胃癌发病和死亡趋势分析[J]. 预防医学, 2023, 35(7): 557-562.
[3]	安静, 李辉, 盛红斌, 蒋琦. 2012—2021年湖州市5岁以下儿童死亡监测资料分析[J]. 预防医学, 2023, 35(7): 628-631.
[4]	聂东梅, 李一鹏, 黄妍. 2012—2021年江门市4类慢性病早死概率分析[J]. 预防医学, 2023, 35(7): 602-606.
[5]	王永, 应焱燕, 陈洁平, 崔军, 包凯芳, 李思萱, 朱银潮, 王思嘉, 徐典, 冯宏伟. 2002—2022年宁波市恶性肿瘤死亡趋势分析[J]. 预防医学, 2023, 35(6): 496-500,505.
[6]	初里楠, 董奕, 李竹, 张燕, 朱丹红. 2014—2021年西城区恶性肿瘤死亡及减寿分析[J]. 预防医学, 2023, 35(5): 410-414.
[7]	崔俊鹏, 陆艳, 黄春妍, 华钰洁, 王临池. 2007—2021年苏州市女性乳腺癌死亡与减寿分析[J]. 预防医学, 2023, 35(5): 380-383.
[8]	周洁, 谭自明, 茹凉. 1990年与2019年中国0~14岁儿童肿瘤疾病负担分析[J]. 预防医学, 2023, 35(3): 205-209.
[9]	张瑞洁, 纪威, 韩丽媛, 张良. 2012—2021年宁波市脑卒中发病和死亡趋势分析[J]. 预防医学, 2023, 35(3): 224-228.
[10]	项彩英, 汪德兵. 2011—2022年开化县肺癌发病和死亡趋势分析[J]. 预防医学, 2023, 35(10): 885-889.
[11]	张艳, 徐珏, 付文, 刘庆敏. 2006—2020年杭州市脑血管病死亡趋势分析[J]. 预防医学, 2022, 34(9): 881-886,892.
[12]	丁晶莹, 俞梅华, 沈益妹. 2012—2021年湖州市居民溺水死亡及寿命损失分析[J]. 预防医学, 2022, 34(7): 676-680.
[13]	高明妃, 胡如英, 胡崇高. 中国糖尿病死亡流行特征研究进展[J]. 预防医学, 2022, 34(7): 692-695.
[14]	王倩倩, 徐丽. 2015—2019年武义县居民恶性肿瘤死亡趋势分析[J]. 预防医学, 2022, 34(7): 732-737.
[15]	吴倩, 张钰, 刘魁, 王伟, 陈彬, 陈松华. 2016—2020年浙江省肺结核流行特征分析[J]. 预防医学, 2022, 34(5): 487-491.

Viewed

Full text

Abstract

Cited

Shared

Discussed